Missed Opportunities for HIV Prevention in a Large County Safety Net Health System

References

1. 1.↵
   Centers for Disease Control and Prevention. HIV Surveillance Report, 2021; vol. 34. Available at: https://www.cdc.gov/hiv/library/reports/hiv-surveillance/vol-34/index.html. Published May 2023. Accessed [June 9, 2023].
2. 2.↵
   1. Fauci AS,
   2. Redfield RR,
   3. Sigounas G,
   4. Weahkee MD,
   5. Giroir BP

   . Ending the HIV Epidemic: A Plan for the United States. JAMA 2019;321:844–5.

   OpenUrlCrossRefPubMed
3. 3.↵
   1. Grant RM,
   2. Lama JR,
   3. Anderson PL

   , iPrEx Study Teamet al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med 2010;363:2587–99.

   OpenUrlCrossRefPubMedWeb of Science
4. 4.
   1. Baeten JM,
   2. Donnell D,
   3. Ndase P

   , Partners PrEP Study Teamet al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med 2012;367:399–410.

   OpenUrlCrossRefPubMedWeb of Science
5. 5.↵
   1. Choopanya K,
   2. Martin M,
   3. Suntharasamai P

   , Bangkok Tenofovir Study Groupet al. Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet 2013;381:2083–90.

   OpenUrlCrossRefPubMedWeb of Science
6. 6.↵
   Centers for Diseases Control and Prevention. Effectiveness of Prevention Strategies to Reduce the Risk of Acquiring or Transmitting HIV. Updated June 17, 2022. Accessed April 25, 2023. Available at: https://www.cdc.gov/hiv/risk/estimates/preventionstrategies.html.
7. 7.↵
   1. Landovitz RJ,
   2. Donnell D,
   3. Clement ME

   , HPTN 083 Study Teamet al. Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women. N Engl J Med 2021;385:595–608.

   OpenUrlCrossRefPubMed
8. 8.↵
   1. Delany-Moretlwe S,
   2. Hughes JP,
   3. Bock P

   , HPTN 084 study groupet al. Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial [published correction appears in Lancet. Lancet. 2022;399:1779–89. 2022 May 7;399(10337):1778].

   OpenUrlCrossRefPubMed
9. 9.↵
   Centers for Disease Control and Prevention: US Public Health Service: Preexposure prophylaxis for the prevention of HIV infection in the United States—2021 Update: a clinical practice guideline. Accessed April 25, 2023. Available at: https://www.cdc.gov/hiv/pdf/risk/prep/cdc-hiv-prep-guidelines-2021.pdf.
10. 10.↵
    1. Owens DK,
    2. Davidson KW,
    3. Krist AH

    , US Preventive Services Task Forceet al. Preexposure Prophylaxis for the Prevention of HIV Infection: US Preventive Services Task Force Recommendation Statement. JAMA 2019;321:2203–13.

    OpenUrlCrossRefPubMed
11. 11.↵
    Centers for Diseases Control and Prevention. Monitoring selected national HIV prevention and care objectives by using HIV surveillance data—United States and 6 dependent areas, 2021. HIV Surveillance Supplemental Report 2023;28.
12. 12.↵
    1. Palaiodimos L,
    2. Herman HS,
    3. Wood E,
    4. et al

    . Practices and Barriers in Sexual History Taking: A Cross-Sectional Study in a Public Adult Primary Care Clinic. J Sex Med 2020;17:1509–19.

    OpenUrlCrossRefPubMed
13. 13.
    1. Hoover KW,
    2. Huang YA,
    3. Tanner ML,
    4. et al

    . HIV Testing Trends at Visits to Physician Offices, Community Health Centers, and Emergency Departments—United States, 2009–2017. MMWR Morb Mortal Wkly Rep 2020;69:776–80. Available at: http://dx.doi.org/10.15585/mmwr.mm6925a2.

    OpenUrlCrossRef
14. 14.↵
    1. Barnes A,
    2. Jetelina KK,
    3. Betts AC,
    4. Mendoza T,
    5. Sreeramoju P,
    6. Tiro JA

    . Emergency Department Testing Patterns for Sexually Transmitted Diseases in North Texas. Sex Transm Dis 2019;46:434–9.

    OpenUrl
15. 15.↵
    1. Hill SV,
    2. Westfall AO,
    3. Coyne-Beasley T,
    4. Simpson T,
    5. Elopre L

    . Identifying Missed Opportunities for Human Immunodeficiency Virus Pre-exposure Prophylaxis During Preventive Care and Reproductive Visits in Adolescents in the Deep South. Sex Transm Dis 2020;47:88–95.

    OpenUrl
16. 16.↵
    1. Watson DL,
    2. Shaw PA,
    3. Petsis DT,
    4. et al

    . A retrospective study of HIV pre-exposure prophylaxis counselling among non-Hispanic Black youth diagnosed with bacterial sexually transmitted infections in the United States, 2014-2019. J Int AIDS Soc 2022;25:e25867.

    OpenUrl
17. 17.↵
    1. Lions C,
    2. Laroche H,
    3. Mora M,
    4. et al

    . Missed opportunities for HIV pre-exposure prophylaxis among people with recent HIV infection: The French ANRS 95041 OMaPrEP study. HIV Med 2023;24:191–201.

    OpenUrl
18. 18.↵
    1. Vincent W,
    2. McFarland W

    . Missed opportunities for healthcare providers to discuss HIV preexposure prophylaxis with people who inject drugs. Int J Drug Policy 2022;110:103873.

    OpenUrl
19. 19.↵
    1. van Buuren S,
    2. Groothuis-Oudshoorn K

    . 2011. mice: Multivariate Imputation by Chained Equations in R. J Stat Soft 2011;45:1–67.

    OpenUrl
20. 20.↵
    1. Workowski KA,
    2. Bachmann LH,
    3. Chan PA,
    4. et al

    . Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep 2021;70:1–187.

    OpenUrlCrossRefPubMed
21. 21.↵
    Texas Department of State Health Services. Texas HIV Surveillance Report, 2019. Available at: https://www.dshs.texas.gov/sites/default/files/hivstd/reports/HIVSurveillanceReport.pdf. Published April 1, 2021. Accessed July 7, 2023.
22. 22.↵
    1. Davidson KW,
    2. Barry MJ,
    3. Mangione CM

    , US Preventive Services Task Forceet al. Screening for Chlamydia and Gonorrhea: US Preventive Services Task Force Recommendation Statement. JAMA 2021;326:949–56.

    OpenUrl
23. 23.↵
    Centers for Diseases Control and Prevention. HIV Testing. Available at: https://www.cdc.gov/hiv/testing/index.html#:∼:text=CDC%20recommends%20that%20everyone%20between,at%20least%20once%20a%20year. Published June 9, 2022. Accesed July 7, 2023.
24. 24.↵
    1. Traynor SM,
    2. Rosen-Metsch L,
    3. Feaster DJ

    . Missed Opportunities for HIV Testing Among STD Clinic Patients. J Community Health 2018;43:1128–36.

    OpenUrl
25. 25.↵
    1. Sell J,
    2. Chen R,
    3. Huber C,
    4. Parascando J,
    5. Nunez J

    . Primary Care Provider HIV PrEP Knowledge, Attitudes, and Prescribing Habits: A Cross-Sectional Survey of Late Adopters in Rural and Suburban Practice. J Prim Care Community Health 2023;14:21501319221147254.

    OpenUrl
26. 26.↵
    Increase the proportion of people with a usual primary care provider—AHS-07. Healthy People 2030. US Department of Health and Human Services. Accessed April 26, 2023. Available at: https://health.gov/healthypeople/objectives-and-data/browse-objectives/health-care-access-and-quality/increase-proportion-people-usual-primary-care-provider-ahs-07.
27. 27.↵
    1. Haukoos JS,
    2. White DAE,
    3. Rowan SE,
    4. et al

    . HIV Risk and Pre-Exposure Prophylaxis Eligibility Among Emergency Department Patients. AIDS Patient Care STDS 2021;35:211–9.

    OpenUrl
28. 28.↵
    1. Kulie P,
    2. Castel AD,
    3. Zheng Z,
    4. et al

    . Targeted Screening for HIV Pre-Exposure Prophylaxis Eligibility in Two Emergency Departments in Washington, DC. AIDS Patient Care STDS 2020;34:516–22.

    OpenUrl